NMR Spectroscopy-Based Metabolic Profiling of Drug-Induced Changes In Vitro Can Discriminate between Pharmacological Classes
暂无分享,去创建一个
Mats G. Gustafsson | Ulf Hammerling | Obaid Aftab | Mikael K. R. Engskog | Jakob Haglöf | Albert Elmsjö | Torbjörn Arvidsson | Curt Pettersson | J. Haglöf | C. Pettersson | M. Gustafsson | M. Engskog | T. Arvidsson | U. Hammerling | O. Aftab | A. Elmsjö
[1] D G Robertson,et al. Metabolomics in Drug Discovery and Development , 2013, Clinical pharmacology and therapeutics.
[2] L. Frydman,et al. Two-dimensional RF pulses: a new approach to selectively exciting J-coupled spins in nuclear magnetic resonance. , 2013, The Journal of chemical physics.
[3] Ronan M. T. Fleming,et al. A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.
[4] Nigel W. Hardy,et al. Proposed minimum reporting standards for chemical analysis , 2007, Metabolomics.
[5] T. Ebbels,et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts , 2007, Nature Protocols.
[6] A. Fernie,et al. Metabolite profiling: from diagnostics to systems biology , 2004, Nature Reviews Molecular Cell Biology.
[7] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[8] S. Thomas,et al. Use of SERMs for treatment in postmenopausal women , 2014, The Journal of Steroid Biochemistry and Molecular Biology.
[9] A. Zhang,et al. NMR‐based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis , 2013, Magnetic resonance in chemistry : MRC.
[10] David S. Wishart,et al. HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..
[11] D. Ekman,et al. A direct cell quenching method for cell-culture based metabolomics , 2009, Metabolomics.
[12] J. Lindon,et al. Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.
[13] Yongzhi Yang,et al. Metabolomics in the fields of oncology: a review of recent research , 2012, Molecular Biology Reports.
[14] Claes R. Andersson,et al. Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance , 2013, BMC Cancer.
[15] Kanika Chawla,et al. Oncometabolomics in cancer research , 2013, Expert review of proteomics.
[16] H. Koltai,et al. Specificity of DNA microarray hybridization: characterization, effectors and approaches for data correction , 2008, Nucleic acids research.
[17] R. Tagliaferri,et al. Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.
[18] A. Tomassini,et al. Effects of resveratrol on HepG2 cells as revealed by (1)H-NMR based metabolic profiling. , 2012, Biochimica et biophysica acta.
[19] M. Tashiro,et al. BASHD‐J‐resolved‐COSY: a new method for measuring proton‐proton spin coupling constants of multiplet signals , 2012, Magnetic resonance in chemistry : MRC.
[20] N. Bouchemal,et al. Metabolomic profiling with NMR discriminates between biphosphonate and doxorubicin effects on B16 melanoma cells , 2010, NMR in biomedicine.
[21] Xi-jun Wang,et al. Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies. , 2011, Journal of separation science.
[22] Joel Dudley,et al. Exploiting drug-disease relationships for computational drug repositioning , 2011, Briefings Bioinform..
[23] A. Isaksson,et al. Phenotype-Based Screening of Mechanistically Annotated Compounds in Combination with Gene Expression and Pathway Analysis Identifies Candidate Drug Targets in a Human Squamous Carcinoma Cell Model , 2006, Journal of biomolecular screening.
[24] Mårten Fryknäs,et al. In Vitro Drug Sensitivity-Gene Expression Correlations Involve a Tissue of Origin Dependency , 2007, J. Chem. Inf. Model..
[25] M. Tashiro,et al. Selective COSY‐J‐resolved‐HMBC, a new method for improving sensitivity of cross peaks of methine proton signals attached to a methyl group , 2012, Magnetic resonance in chemistry : MRC.
[26] Ying Zhang,et al. HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..
[27] Mårten Fryknäs,et al. Inhibition of proteasome deubiquitinating activity as a new cancer therapy , 2011, Nature Medicine.
[28] Mårten Fryknäs,et al. Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer , 2013, Journal of Cancer Research and Clinical Oncology.
[29] G. Westman,et al. Phenotype-based drug screening in primary ovarian carcinoma cultures identifies intracellular iron depletion as a promising strategy for cancer treatment. , 2011, Biochemical pharmacology.
[30] W. N. Chen,et al. Metabolic profiling of HepG2 cells incubated with S(−) and R(+) enantiomers of anti-coagulating drug warfarin , 2010, Metabolomics.
[31] Giovanni Paternostro,et al. Metabolomic high-content nuclear magnetic resonance-based drug screening of a kinase inhibitor library. , 2011, Nature communications.
[32] R. Larsson,et al. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system. , 2012, Experimental cell research.
[33] H. Keun,et al. Application of metabonomics in drug development. , 2007, Pharmacogenomics.
[34] D. Kell,et al. Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery☆ , 2014, Drug discovery today.
[35] Justin Lamb,et al. The Connectivity Map: a new tool for biomedical research , 2007, Nature Reviews Cancer.
[36] V. Gogvadze,et al. Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments , 2014, Nature Communications.
[37] L. Påhlman,et al. Novel activity of acriflavine against colorectal cancer tumor cells , 2011, Cancer science.
[38] Xi-jun Wang,et al. Modern analytical techniques in metabolomics analysis. , 2012, The Analyst.
[39] S. Linder,et al. Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells. , 2013, Biochemical and biophysical research communications.
[40] M. Čuperlović-Culf,et al. Cell culture metabolomics: applications and future directions. , 2010, Drug discovery today.
[41] Mark R. Viant,et al. Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines , 2009, PloS one.